Loading clinical trials...
Loading clinical trials...
The purpose of this registry is to observe longterm performance and safety of the JenaValve TAVI system, in routine medical and everyday conditions.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
JenaValve Technology, Inc.
Collaborators
NCT06638268 · Aortic Stenosis, Cardiogenic Shock
NCT07197736 · Valve Disease, Aortic, Mitral Regurgitation (MR), and more
NCT07469371 · Severe Aortic Stenosis
NCT07278310 · Symptomatic Severe Native Aortic Stenosis, Aortic Stenosis
NCT07453407 · Aortic Regurgitation, Aortic Valve Insufficiency, and more
Herz- und Diabeteszentrum NRW
Bad Oeynhausen
Herzzentrum der Universität
Cologne
Herzzentrum Dresden, Universitätsklinik an der Technischen Universität Dresden
Dresden
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions